Earlier this year, Anuncia Inc., a medical device company focused on the development of treatment devices for hydrocephalus and other cerebrospinal fluid (CSF) disorders, announced that the ReFlowTM System Mini received the U.S Food and Drug Administration (FDA) Breakthrough Device Designation. The ReFlowTM System Mini is the next generation version of the commercial ReFlowTM Ventricular System.

Read More

The Hydrocephalus Association collaborates with various organizations and coalitions on policy issues that affect the hydrocephalus community. By partnering with other like-minded organizations, we can provide a stronger, unified voice…

Read More

The Hydrocephalus Association discloses the financial support it receives from all sponsors. The following disclosure information includes the total amount of support received from each corporate sponsor in 2020. The…

Read More